R2 Technology is making machines smarter and, in the process, easing the transition to digital mammography.
R2 Technology is making machines smarter and, in the process, easing the transition to digital mammography.
The CAD developer's Citra Mammography Applications Suite, launched at the 2005 RSNA meeting, includes software tools that automatically scale mammograms to the display window, sizing the previous mammogram with the current image, regardless of the system used to capture the images or the amount of compression placed on the breasts.
In a separate development, the company enhanced its ImageChecker mammography CAD technology. One new feature, built into Version 8.1, identifies regions of breast tissue that contain both a mass and calcifications. Another assigns variable-sized CAD marks to indicate the potential for malignancy.
This latest version also allows users to set the sensitivity of the machine to flag more or fewer anomalies. Separate controls are available for microcalcifications and for masses.
The introductions reflect a corporate strategy to promote the use of CAD as a way to make radiologists' lives easier. This strategy, and how it will affect R2 products in the future, will be featured in the next issue of DI SCAN, available online Dec. 19.
Mammography and Breast MRI: Is it Time to Evaluate Strategies as Opposed to Modalities?
July 5th 2024The combination of mammography with breast MRI within 90 days had a 96.2 percent sensitivity in comparison to 48.1 percent for mammography and 79.7 percent for breast MRI performed within 91 to 270 days after index mammography, according to newly published research.
ACR Collaborative Model Leads to 35 Percent Improvement with Mammography Positioning Criteria
July 1st 2024Noting significant variation with facilities for achieving passing criteria for mammography positioning, researchers found that structured interventions, ranging from weekly auditing of images taken by technologists to mechanisms for feedback from radiologists to technologists, led to significant improvements in a multicenter study.